Merck & Co. Gain (Loss) on Cenovus Energy Investment decreased by 55.0% to $168.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 86.7%, from $90.00M to $168.00M. Over 2 years (FY 2021 to FY 2023), Gain (Loss) on Cenovus Energy Investment shows a downward trend with a -58.0% CAGR.
cop_gain_loss_on_cenovus_investment| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $280.00M | $683.00M | $405.00M | -$708.00M | -$284.00M | -$371.00M | -$58.00M | $450.00M | -$175.00M | -$33.00M | $100.00M | $143.00M | $56.00M | -$31.00M | $90.00M | $100.00M | $373.00M | $168.00M |
| QoQ Change | — | +143.9% | -40.7% | -274.8% | +59.9% | -30.6% | +84.4% | +875.9% | -138.9% | +81.1% | +403.0% | +43.0% | -60.8% | -155.4% | +390.3% | +11.1% | +273.0% | -55.0% |
| YoY Change | — | — | — | — | -201.4% | -154.3% | -114.3% | +163.6% | +38.4% | +91.1% | +272.4% | -68.2% | +132.0% | +6.1% | -37.1% | +78.6% | >999% | +86.7% |